Wall Street Analysts See an 80.12% Upside in Q32 Bio (QTTB): Can the Stock Really Move This High?

Q32 Bio (QTTB) faces an implied 80.1% upside to the consensus price target, but the article notes this metric is not a reliable predictor. It highlights an improving trend in earnings estimate revisions as the more actionable near-term catalyst for potential upside.

Analysis

Q32 Bio (QTTB) faces an implied 80.1% upside to the consensus price target, but the article notes this metric is not a reliable predictor. It highlights an improving trend in earnings estimate revisions as the more actionable near-term catalyst for potential upside.